New research further solidifies findings that aspirin could be a powerful anti-cancer drug, at least in some specific cases.

Mario Hermoso does not wish to return to the Italian capital after enjoying his spell with Bayer Leverkusen.In fact, Hermoso ...

Aspirin, a widely available and inexpensive drug, has failed to improve survival or reduce recurrence rates in women with early-stage but high-risk breast cancer, according to a Harvard-led clinical ...

Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart ...

Researchers from Florida Atlantic University argue that doctors should consider each patient's individual risk profile rather ...

Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease. The American Heart ...

Researchers stress that patients should consult their primary care provider about whether they are candidates for aspirin, as providers have the most knowledge of all the benefits and risks for each ...

Research has led to a new understanding of how aspirin stimulates the immune system to reduce the metastasis of some early ...

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%. | Drug Discovery And ...

Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...

Aspirin and COX-1 inhibitors boost immunity against cancer metastasis, revealing a new pathway for anti-metastatic therapies.